0,950  0,001  Glutamate decarboxylase inhibitor
0,938  0,002  GST A substrate
0,823  0,001  Glutamate dehydrogenase inhibitor
0,798  0,001  GABA C receptor agonist
0,790  0,002  Arylamine N-Acetyltransferase substrate
0,778  0,007  Radioprotector
0,760  0,010  TNF expression inhibitor
0,744  0,001  Glutamate (mGluR6) antagonist
0,743  0,005  Platelet antagonist
0,740  0,002  Tyrosine 3 hydroxylase inhibitor
0,745  0,007  Chemoprotective
0,737  0,002  GST P1-1 substrate
0,736  0,004  Superoxide dismutase inhibitor
0,729  0,005  Stroke treatment
0,731  0,014  Teratogen
0,714  0,003  Peroxidase inhibitor
0,700  0,004  Flavin-containing monooxygenase substrate
0,686  0,001  Excitatory amino acid transporter EAAC1 inhibitor
0,698  0,015  Embryotoxic
0,682  0,005  Psychostimulant
0,679  0,003  FMO3 substrate
0,671  0,007  NOS3 expression inhibitor
0,660  0,001  Carbamoyl phosphate synthetase inhibitor
0,651  0,003  Phospholipase C inhibitor
0,635  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,631  0,009  Immunomodulator
0,630  0,008  Histamine release inhibitor
0,626  0,004  Interleukin agonist
0,626  0,006  Ulceration
0,630  0,012  5 Hydroxytryptamine release stimulant
0,617  0,005  FMO1 substrate
0,618  0,010  Cytostatic
0,614  0,010  Antipruritic, allergic
0,605  0,001  Argininosuccinate synthase inhibitor
0,628  0,026  Antiarthritic
0,606  0,005  Septic shock treatment
0,611  0,013  Analeptic
0,594  0,002  Fumarate hydratase inhibitor
0,590  0,002  Ornithine carbamoyltransferase inhibitor
0,591  0,005  Acute neurologic disorders treatment
0,585  0,007  Angiogenesis stimulant
0,576  0,002  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,575  0,003  5 Hydroxytryptamine uptake stimulant
0,575  0,004  Interleukin 2 agonist
0,572  0,002  NMDA receptor agonist
0,573  0,004  Growth hormone agonist
0,567  0,002  Histidine decarboxylase inhibitor
0,584  0,021  Aldehyde oxidase inhibitor
0,565  0,004  Hematopoietic
0,561  0,004  Integrin antagonist
0,560  0,004  Glutathione S-transferase substrate
0,570  0,019  Carcinogenic
0,544  0,005  Thrombolytic
0,550  0,011  Eye irritation, high
0,541  0,002  Phenylalanine 4-hydroxylase inhibitor
0,545  0,007  Myocardial infarction treatment
0,557  0,021  Antithrombotic
0,549  0,014  Antiischemic
0,532  0,002  Phosphofructokinase-1 inhibitor
0,541  0,015  Apoptosis antagonist
0,526  0,003  Porphobilinogen synthase inhibitor
0,522  0,003  Leukotriene A4 hydrolase inhibitor
0,520  0,004  Carcinogenic, group 1
0,531  0,018  Cardioprotectant
0,517  0,004  Antidote
0,548  0,038  Antidiabetic
0,548  0,038  Cyclophilin D inhibitor
0,530  0,023  Bone diseases treatment
0,509  0,003  Antispirochetal
0,506  0,002  Catalase inhibitor
0,521  0,018  Interleukin antagonist
0,522  0,024  Antihypercholesterolemic
0,527  0,028  Cholesterol antagonist
0,524  0,026  Immunostimulant
0,497  0,001  Glutamate (mGluR6) agonist
0,499  0,008  Radiosensitizer
0,499  0,009  Wound healing agent
0,498  0,010  Antihypoxic
0,489  0,003  GABA aminotransferase inhibitor
0,497  0,011  UGT2B4 substrate
0,481  0,001  Excitatory amino acid transporter 2 inhibitor
0,483  0,007  Antineoplastic antimetabolite
0,493  0,023  CTGF expression inhibitor
0,471  0,004  Cell adhesion inhibitor
0,477  0,011  Anticoagulant
0,467  0,003  NAT2 substrate
0,477  0,014  UGT1A6 substrate
0,491  0,030  Vasodilator, peripheral
0,460  0,002  Adenylate kinase inhibitor
0,455  0,003  Ferrochelatase inhibitor
0,470  0,024  Antiosteoporotic
0,482  0,039  5 Hydroxytryptamine release inhibitor
0,459  0,016  DNA synthesis inhibitor
0,467  0,028  Hepatic disorders treatment
0,444  0,008  DNA methylase inhibitor
0,437  0,003  Glutamate (mGluR group III) agonist
0,438  0,005  Pancreatic disorders treatment
0,436  0,004  Alcohol oxidase inhibitor
0,455  0,025  Antihypertensive
0,434  0,007  Antipruritic, non-allergic
0,430  0,004  Antineoplastic, alkylator
0,427  0,004  Aminopeptidase B inhibitor
0,426  0,007  DNA methyltransferase I inhibitor
0,415  0,001  Excitatory amino acid transporter 1 inhibitor
0,431  0,017  Insulysin inhibitor
0,433  0,025  Antidiabetic (type 2)
0,453  0,046  Immunosuppressant
0,425  0,021  Antidiabetic symptomatic
0,406  0,003  Triose-phosphate isomerase inhibitor
0,428  0,027  Mutagenic
0,404  0,004  Cell adhesion molecule inhibitor
0,408  0,010  UGT2B7 substrate
0,444  0,047  Atherosclerosis treatment
0,402  0,006  Insulin sensitizer
0,397  0,004  Succinate dehydrogenase inhibitor
0,390  0,001  Glutamate (mGluR8) agonist
0,390  0,003  NMDA 2C receptor antagonist
0,389  0,004  Coagulant
0,388  0,003  SULT1A1 substrate
0,411  0,027  Proliferative diseases treatment
0,386  0,004  Alcohol dehydrogenase inhibitor
0,387  0,006  Corneal wound healing stimulator
0,420  0,041  Respiratory analeptic
0,396  0,022  Vascular (periferal) disease treatment
0,407  0,034  UGT1A9 substrate
0,406  0,035  Cytotoxic
0,388  0,018  Abortion inducer
0,370  0,002  Glutamate (mGluR4) antagonist
0,395  0,028  Hypoglycemic
0,374  0,008  Antidiabetic (type 1)
0,379  0,015  Hepatoprotectant
0,369  0,007  Gastrin inhibitor
0,380  0,021  Platelet aggregation inhibitor
0,364  0,004  Aminoacyl-tRNA synthetase inhibitor
0,362  0,006  Cystathionine beta-synthase inhibitor
0,363  0,007  Renal failure treatment
0,364  0,016  Antihypotensive
0,349  0,002  Glutamate (mGluR3) antagonist
0,360  0,013  Antialcoholic
0,367  0,021  Anesthetic general
0,353  0,008  Insulin secretagoues
0,346  0,003  Glutamate (mGluR4) agonist
0,352  0,010  Shock treatment
0,368  0,025  Antiulcerative
0,350  0,008  Aldehyde dehydrogenase inhibitor
0,343  0,001  Lysine carboxypeptidase inhibitor
0,402  0,063  Transcription factor NF kappa B inhibitor
0,346  0,008  Cell wall synthesis inhibitor
0,363  0,026  Antineoplastic (lymphocytic leukemia)
0,366  0,029  Vasodilator
0,400  0,063  CYP2C9 substrate
0,367  0,030  Sodium/bile acid cotransporter inhibitor
0,354  0,019  Antimutagenic
0,336  0,004  GP IIb/IIIa receptor antagonist
0,334  0,003  Folate antagonist
0,341  0,012  Sepsis treatment
0,329  0,002  Glutamate (mGluR1) agonist
0,420  0,094  Antineoplastic (solid tumors)
0,366  0,039  NOS2 expression inhibitor
0,339  0,013  Bone formation stimulant
0,402  0,076  Antibacterial
0,347  0,023  UGT1A4 substrate
0,331  0,007  Antiviral (Poxvirus)
0,335  0,015  Interferon gamma antagonist
0,336  0,017  Diabetic retinopathy treatment
0,335  0,016  Carcinogenic, group 3
0,320  0,002  Glutamate (mGluR group III) antagonist
0,325  0,010  Sulfotransferase substrate
0,335  0,021  Skin irritative effect
0,331  0,018  Diuretic
0,321  0,009  Antihyperlipoproteinemic
0,314  0,003  AMPA 4 receptor antagonist
0,314  0,003  GST T1-1 substrate
0,313  0,002  Aconitate hydratase inhibitor
0,334  0,024  Platelet adhesion inhibitor
0,380  0,071  GABA C receptor rho-3 antagonist
0,315  0,008  Expectorant
0,329  0,023  Antianginal
0,410  0,105  Caspase 9 stimulant
0,305  0,001  Glutamate (mGluR1a) agonist
0,317  0,014  Hemostatic
0,307  0,004  NAT1 substrate
0,305  0,003  Kainate receptor antagonist
0,332  0,030  GST M1-1 substrate
0,313  0,012  Alkylator
0,304  0,003  Ornithine decarboxylase inhibitor
0,330  0,029  UDP-glucuronosyltransferase substrate
0,308  0,008  Antianemic
0,354  0,056  CYP2D6 substrate
0,301  0,004  Glycine transporter 2 inhibitor
0,324  0,027  UGT1A1 substrate
0,304  0,008  UGT2B1 substrate
0,308  0,013  Neurotensin receptor agonist
0,357  0,064  Antiallergic
0,366  0,073  CYP3A4 substrate
0,305  0,013  Phospholipase A2 inhibitor
0,311  0,018  Hair growth stimulant
0,308  0,017  Muscular dystrophy treatment
0,296  0,005  Catenin beta inhibitor
0,294  0,003  Aminopeptidase I inhibitor
0,334  0,045  Antipyretic
0,292  0,005  Toll-Like receptor 2 antagonist
0,296  0,009  Antiviral (West Nile virus)
0,345  0,059  AR expression inhibitor
0,306  0,020  UGT1A3 substrate
0,308  0,022  Peptidyltransferase inhibitor
0,289  0,004  Mucolytic
0,325  0,042  Antiglaucomic
0,292  0,009  Histone deacetylase SIRT1 inhibitor
0,297  0,014  Antidiarrheal
0,286  0,004  Inducible nitric-oxide synthase inhibitor
0,333  0,051  Antioxidant
0,325  0,044  Cardiodepressant
0,302  0,022  Antianorexic
0,286  0,007  Age-related macular degeneration treatment
0,286  0,009  Uterine stimulant
0,320  0,046  Cardiovascular analeptic
0,303  0,029  Myocardial ischemia treatment
0,281  0,013  Pulmonary hypertension treatment
0,272  0,004  Antirickettsial
0,296  0,029  Non-steroidal antiinflammatory agent
0,271  0,004  NMDA receptor subunit 3B antagonist
0,312  0,045  Pyruvate kinase inhibitor
0,267  0,003  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,273  0,008  Antieczematic
0,269  0,006  Glutamate receptor agonist
0,312  0,049  Free radical scavenger
0,265  0,001  Kainate receptor agonist
0,333  0,070  ICAM1 expression inhibitor
0,266  0,003  Glutathione S-transferase inhibitor
0,269  0,008  NMDA receptor antagonist
0,289  0,029  VCAM1 expression inhibitor
0,263  0,004  Integrin alpha4 antagonist
0,268  0,009  UGT2B10 substrate
0,327  0,068  Vasodilator, coronary
0,260  0,002  Kainate receptor 1 antagonist
0,260  0,003  Glutamate (mGluR7) agonist
0,270  0,015  Aldehyde oxidase substrate
0,276  0,022  Amylase inhibitor
0,257  0,004  NMDA receptor subunit 3A antagonist
0,307  0,054  DNA damaging
0,256  0,005  Nitric-oxide synthase inhibitor
0,290  0,039  Antiparkinsonian, rigidity relieving
0,263  0,014  SULT1A3 substrate
0,253  0,004  DOPA decarboxylase inhibitor
0,255  0,005  Photosensitizer
0,252  0,004  Adenylate cyclase stimulant
0,251  0,004  Antidote, heavy metal
0,245  0,003  Kainate receptor 2 antagonist
0,247  0,004  Prolactin inhibitor
0,266  0,024  Antiparkinsonian, tremor relieving
0,266  0,024  Antiischemic, cerebral
0,251  0,010  Anticataract
0,242  0,003  Glycine receptor agonist
0,243  0,004  Biliverdin reductase inhibitor
0,305  0,069  Antineoplastic (endocrine cancer)
0,293  0,057  Sensitization
0,242  0,007  Glutamate (mGluR) agonist
0,239  0,004  NMDA 2A receptor antagonist
0,263  0,030  Macular degeneration treatment
0,246  0,014  Cathepsin H inhibitor
0,242  0,010  Antifungal (Cryptococcus)
0,277  0,046  Chemopreventive
0,326  0,095  Toll-Like receptor agonist
0,238  0,008  Antimetabolite
0,237  0,008  GABA C receptor antagonist
0,274  0,048  Anticonvulsant
0,296  0,072  Spasmolytic
0,266  0,042  Neuropeptide Y2 antagonist
0,249  0,026  CNS active muscle relaxant
0,240  0,018  Chelator
0,269  0,048  Antihypertriglyceridemic
0,238  0,017  Glutamate receptor antagonist
0,239  0,019  Psychosexual dysfunction treatment
0,231  0,012  Raynaud's phenomenon treatment
0,229  0,012  Histone deacetylase class III inhibitor
0,227  0,010  Contraceptive female
0,253  0,036  CYP2B6 inhibitor
0,219  0,004  Sphingosine 1-phosphate receptor 4 agonist
0,222  0,008  Vanilloid 1 agonist
0,240  0,025  Acute respiratory distress syndrome (ARDS) treatment
0,226  0,012  Cyclooxygenase 3 inhibitor
0,228  0,014  Retinoprotector
0,241  0,027  Cystic fibrosis treatment
0,243  0,029  UGT2B15 substrate
0,233  0,020  Antiviral (Ebola)
0,220  0,006  Carbonic anhydrase stimulant
0,219  0,006  Toll-Like receptor 2 agonist
0,216  0,003  Kainate receptor 5 antagonist
0,253  0,041  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,213  0,002  Arginase inhibitor
0,239  0,029  Thiol protease inhibitor
0,208  0,001  Excitatory amino acid transporter 3 inhibitor
0,217  0,010  Aldehyde dehydrogenase substrate
0,210  0,003  AMPA 3 receptor antagonist
0,236  0,030  Protein kinase stimulant
0,209  0,004  Restless leg syndrome treatment
0,237  0,033  Restenosis treatment
0,241  0,037  Lipocortins synthesis antagonist
0,226  0,022  Adenylate cyclase inhibitor
0,213  0,009  NADH dehydrogenase inhibitor
0,217  0,015  Cathepsin G inhibitor
0,204  0,004  AMPA 2 receptor antagonist
0,216  0,016  Nav1.4 sodium channel blocker
0,279  0,079  CYP1A2 substrate
0,230  0,032  Antipruritic
0,300  0,104  Antineoplastic (non-Hodgkin's lymphoma)
0,198  0,004  Antifungal (Pneumocystis)
0,201  0,008  GABA C receptor rho-1 antagonist
0,194  0,001  Glutamate (mGluR3) agonist
0,264  0,073  Transcription factor STAT3 inhibitor
0,267  0,076  Transcription factor STAT inhibitor
0,193  0,003  Kainate receptor 3 antagonist
0,191  0,003  Antiviral (Parainfluenza)
0,233  0,046  Nitric-oxide synthase stimulant
0,203  0,017  Antischistosomal
0,201  0,016  Growth stimulant
0,191  0,006  Antidote, mercury
0,209  0,025  Arachidonic acid antagonist
0,193  0,009  Sphingosine 1-phosphate receptor 2 antagonist
0,191  0,008  Heat shock protein 70 antagonist
0,194  0,011  Creatine kinase inhibitor
0,194  0,012  Selectin antagonist
0,213  0,033  UGT2B9 substrate
0,217  0,037  Antiacne
0,183  0,004  AMPA 1 receptor antagonist
0,195  0,017  Carbonic anhydrase III inhibitor
0,182  0,004  Integrin beta3 antagonist
0,195  0,017  Constipation treatment
0,188  0,012  Caspase 3 inhibitor
0,183  0,006  Paget's disease treatment
0,180  0,004  GABA B receptor agonist
0,208  0,031  Monophenol monooxygenase inhibitor
0,180  0,005  Macrophage elastase inhibitor
0,264  0,090  Antiepileptic
0,204  0,030  Antifungal enhancer
0,179  0,008  Ca2+-transporting ATPase inhibitor
0,178  0,008  Neurotensin receptor antagonist
0,179  0,009  Factor V inhibitor
0,232  0,062  RNA-directed DNA polymerase inhibitor
0,171  0,002  SULT2A1 substrate
0,200  0,032  Antiprotozoal (Coccidial)
0,206  0,038  Melanin inhibitor
0,184  0,017  Interleukin 8 antagonist
0,281  0,115  Inflammatory Bowel disease treatment
0,178  0,013  Antiviral (Papilloma)
0,169  0,004  VLA-4 antagonist
0,204  0,039  Antiviral (Hepatitis C)
0,176  0,012  NMDA 2 receptor antagonist
0,184  0,020  Sphingosine 1-phosphate receptor 5 antagonist
0,212  0,051  Antiviral (Hepatitis)
0,172  0,010  Interleukin 1 beta converting enzyme inhibitor
0,282  0,122  Toll-Like receptor 7 agonist
0,177  0,017  HIV-1 integrase (Overall Integration) inhibitor
0,164  0,005  Cholecystokinin B agonist
0,196  0,037  Genotoxic
0,184  0,026  Carcinogenic, group 2B
0,203  0,045  Protein-tyrosine phosphatase inhibitor
0,163  0,005  CD45 antagonist
0,166  0,008  Acyl-CoA dehydrogenase inhibitor
0,205  0,048  VEGF expression inhibitor
0,169  0,015  Actinic keratosis treatment
0,218  0,063  Sedative
0,159  0,005  Sirtuin 1 inhibitor
0,155  0,005  Caspase 9 inhibitor
0,153  0,003  Thymidylate synthase inhibitor
0,162  0,013  Anabolic
0,149  0,002  Glutamate (mGluR8) antagonist
0,151  0,004  Complement C3a chemotactic receptor antagonist
0,152  0,004  NMDA receptor glycine site agonist
0,153  0,007  Hyperparathyroidism treatment
0,153  0,009  Tourette's syndrome treatment
0,148  0,004  Vitronectin receptor antagonist
0,190  0,047  Interleukin 6 antagonist
0,215  0,073  Antineoplastic enhancer
0,144  0,003  Glutamate (mGluR7) antagonist
0,153  0,012  Tocolytic
0,144  0,003  AICAR transformylase inhibitor
0,157  0,017  Electrolyte absorption antagonist
0,154  0,014  UGT2B11 substrate
0,149  0,010  Glutamate release inhibitor
0,148  0,008  Aminopeptidase microsomal inhibitor
0,227  0,087  Calpain inhibitor
0,238  0,100  CYP2C19 substrate
0,147  0,009  Glucagon-like peptide 1 agonist
0,141  0,003  GABA transporter 3 inhibitor
0,148  0,010  Interferon agonist
0,181  0,044  Aldose reductase substrate
0,148  0,011  Ribonucleoside-diphosphate reductase inhibitor
0,235  0,099  Lipoprotein disorders treatment
0,160  0,024  DNA repair enzyme inhibitor
0,270  0,134  Antiasthmatic
0,235  0,100  Renal disease treatment
0,321  0,186  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,160  0,026  Sphingosine 1-phosphate receptor 4 antagonist
0,146  0,013  Ribonucleotide reductase inhibitor
0,182  0,049  Lipid peroxidase inhibitor
0,138  0,005  Angiotensin-converting enzyme inhibitor
0,148  0,015  Keratolytic
0,148  0,015  Histamine N-methyltransferase inhibitor
0,137  0,005  Sphingosine 1-phosphate receptor 5 agonist
0,151  0,019  Opioid delta receptor antagonist
0,185  0,054  Prostate disorders treatment
0,159  0,029  Choleretic
0,134  0,004  Caspase 2 inhibitor
0,145  0,017  Transcription factor NF kappa B stimulant
0,157  0,030  Alcohol dehydrogenase substrate
0,131  0,004  VCAM antagonist
0,159  0,033  Microtubule formation inhibitor
0,152  0,027  Potassium channel (Ca-activated) activator
0,128  0,003  Glucose-6-phosphate isomerase inhibitor
0,129  0,004  VCAM-1 antagonist
0,200  0,076  Neurotrophic factor enhancer
0,150  0,028  Antiviral (Influenza B)
0,163  0,042  DNA polymerase I inhibitor
0,318  0,198  Antiinflammatory
0,128  0,008  Aminopeptidase N inhibitor
0,124  0,004  Mannosidase inhibitor
0,149  0,030  Protease inhibitor
0,122  0,004  Integrin alphaVbeta3 antagonist
0,122  0,004  GABA transporter 2 inhibitor
0,121  0,003  Membrane dipeptidase inhibitor
0,127  0,009  Anticholelithogenic
0,120  0,004  Kainate receptor 4 antagonist
0,120  0,005  Antidote, organophosphates
0,209  0,094  Antiamyloidogenic
0,132  0,017  Antileprosy
0,142  0,028  Myasthenia Gravis treatment
0,118  0,004  Prostacyclin antagonist
0,136  0,022  Thioredoxin inhibitor
0,142  0,028  Opioid antagonist
0,162  0,049  Movement disorders treatment
0,234  0,121  Antifungal
0,160  0,049  Antiseptic
0,165  0,054  Skeletal muscle relaxant
0,115  0,005  Integrin alpha5beta1 antagonist
0,122  0,012  Narcotic antagonist
0,160  0,052  Hearing loss treatment
0,128  0,020  Factor XII inhibitor
0,140  0,033  Mediator release inhibitor
0,113  0,007  Sphingosine 1-phosphate receptor 1 antagonist
0,115  0,009  Uterine relaxant
0,114  0,009  AMPA receptor antagonist
0,129  0,025  Metalloproteinase-2 inhibitor
0,108  0,005  Alpha-mannosidase inhibitor
0,121  0,019  Bile acid receptor antagonist
0,126  0,023  Opioid mu receptor antagonist
0,148  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,110  0,008  Prostaglandin F2 alpha antagonist
0,110  0,010  Phospholipase D inhibitor
0,104  0,004  Lysophosphatidic acid 3 receptor antagonist
0,132  0,033  Toll-Like receptor 4 antagonist
0,116  0,018  Neutrophil collagenase inhibitor
0,116  0,018  Granulocyte macrophage colony stimulating factor agonist
0,143  0,046  Beta amyloid protein antagonist
0,195  0,098  Hypolipemic
0,121  0,025  Chymotrypsin inhibitor
0,116  0,020  Glycine receptor antagonist
0,103  0,007  Nitric oxide donor
0,137  0,041  TRPA1 agonist
0,099  0,005  Adenine nucleotide translocase inhibitor
0,143  0,051  Proteasome inhibitor
0,245  0,154  Calcium channel activator
0,094  0,003  Calcium-sensing receptor agonist
0,104  0,014  Endothelin-converting enzyme inhibitor
0,128  0,038  UDP-glucose 4-epimerase inhibitor
0,152  0,063  Mannose-6-phosphate isomerase inhibitor
0,101  0,012  Interferon inducer
0,093  0,004  Integrin beta7 antagonist
0,134  0,045  Falcipain 3 inhibitor
0,093  0,004  Endothelial nitric-oxide synthase inhibitor
0,106  0,018  Sphingosine 1-phosphate receptor antagonist
0,090  0,002  Aminopeptidase A inhibitor
0,116  0,028  Antifungal (Candida)
0,116  0,028  Xanthine oxidase substrate
0,102  0,015  Protease 3C (Human rhinovirus) inhibitor
0,166  0,079  Muscle relaxant
0,097  0,011  Plasminogen activator inhibitor antagonist
0,109  0,025  Vanilloid agonist
0,124  0,040  Chronic obstructive bronchitis treatment
0,088  0,004  Integrin alpha4beta7 antagonist
0,092  0,009  Cholecystokinin antagonist
0,100  0,017  Maillard reaction inhibitor
0,092  0,010  Cholecystokinin A antagonist
0,098  0,018  Vanilloid 4 agonist
0,135  0,055  Gastritis treatment
0,094  0,015  Bombesin 2 receptor antagonist
0,087  0,007  Carbonic anhydrase II stimulant
0,090  0,011  Calcitonin receptor agonist
0,157  0,079  Antihelmintic (Nematodes)
0,115  0,037  Carcinogenic, group 2A
0,090  0,012  MDM2 inhibitor
0,081  0,003  Tryptophan 5 hydroxylase inhibitor
0,087  0,009  Kinesin-like protein 1 inhibitor
0,087  0,009  Kinesin antagonist
0,211  0,134  Antipsoriatic
0,085  0,008  Adenosine deaminase inhibitor
0,124  0,047  Antihelmintic (Fasciola)
0,080  0,004  AMPA receptor agonist
0,106  0,030  Somatostatin 1 agonist
0,079  0,004  Integrin alphaVbeta1 antagonist
0,088  0,012  Sphingosine 1-phosphate receptor 3 antagonist
0,150  0,075  Acetylcholine M1 receptor antagonist
0,084  0,009  Anesthetic inhalation
0,146  0,071  Neuropeptide Y1 antagonist
0,089  0,016  Opioid mu receptor agonist
0,088  0,015  Phosphorylase inhibitor
0,081  0,008  Sphingosine 1-phosphate receptor agonist
0,077  0,005  Dihydrofolate reductase inhibitor
0,140  0,067  Anesthetic
0,081  0,009  Glutamate (mGluR group II) agonist
0,148  0,076  GABA C receptor rho-2 antagonist
0,099  0,027  Neuropeptide agonist
0,075  0,003  Carboxypeptidase B inhibitor
0,092  0,021  Trypsin inhibitor
0,180  0,109  Fibrosis treatment
0,129  0,058  Cholesterol synthesis inhibitor
0,078  0,007  Carbonic anhydrase I stimulant
0,098  0,027  Thrombin inhibitor
0,077  0,006  Sphingosine 1-phosphate receptor 1 agonist
0,101  0,031  Analgesic, opioid
0,103  0,033  Antibiotic
0,080  0,011  HCV NS3/NS4A protease inhibitor
0,091  0,021  S-adenosyl-L-methionine decarboxylase inhibitor
0,110  0,041  Lanosterol 14 alpha demethylase inhibitor
0,117  0,048  Urease inhibitor
0,097  0,029  Estrogen-related receptor beta agonist
0,072  0,004  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,099  0,032  Na+ K+ transporting ATPase inhibitor
0,080  0,013  Erythropoietin receptor agonist
0,166  0,099  Antiviral (Influenza)
0,088  0,021  Purinergic P2X1 antagonist
0,070  0,004  Integrin alpha1beta1 antagonist
0,071  0,004  Kynurenine 3 monooxygenase inhibitor
0,073  0,008  Glutamate (mGluR group II) antagonist
0,148  0,083  Neuropathy treatment
0,068  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,102  0,038  Carbonic anhydrase VI inhibitor
0,080  0,017  Botulinum neurotoxin type A inhibitor
0,071  0,008  Dihydropteroate synthase inhibitor
0,105  0,043  Antiviral (Rhinovirus)
0,068  0,005  Integrin alpha2 antagonist
0,078  0,017  Sphingosine kinase inhibitor
0,063  0,003  GRP78 expression inhibitor
0,170  0,110  Pneumotoxic
0,068  0,009  GABA B receptor antagonist
0,080  0,020  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,206  0,147  Metabolic disease treatment
0,131  0,072  Cocaine dependence treatment
0,066  0,007  Glucagon-like peptide 1 receptor antagonist
0,195  0,136  Antineurogenic pain
0,089  0,032  Matrix metalloproteinase inhibitor
0,110  0,052  Antihypermotility
0,087  0,030  Potassium channel large-conductance Ca-activated activator
0,080  0,023  Human rhinovirus A protease inhibitor
0,063  0,006  Dipeptidyl peptidase II inhibitor
0,070  0,016  Antiviral (Herpesvirus 3, Human)
0,089  0,035  Peroxisome proliferator-activated receptor gamma agonist
0,091  0,037  Metalloproteinase-9 inhibitor
0,078  0,024  Antihemophilic
0,086  0,033  MAP kinase kinase 7 inhibitor
0,075  0,022  Matrix metalloproteinase (membrane-type) inhibitor
0,117  0,066  Antiprotozoal (Babesia)
0,126  0,074  Antihelmintic (Trematoda)
0,069  0,018  Thromboxane synthase inhibitor
0,094  0,043  Myeloperoxidase inhibitor
0,059  0,009  Cholecystokinin B antagonist
0,057  0,006  Neutral endopeptidase inhibitor
0,113  0,063  Mental retardation treatment
0,075  0,026  Hypercalcemia treatment
0,052  0,003  Carbonic anhydrase X inhibitor
0,052  0,003  Carbonic anhydrase VIII inhibitor
0,256  0,207  Apoptosis agonist
0,109  0,060  AMP-activated protein kinase stimulant
0,062  0,015  Oxytocin agonist
0,052  0,004  Thyroid hormone agonist
0,054  0,006  Purinergic P2Y12 antagonist
0,058  0,011  GABA uptake inhibitor
0,083  0,036  Antitreponemal
0,055  0,008  Peptide deformylase inhibitor
0,047  0,001  Folate transporter 1 inhibitor
0,058  0,014  Neuraminidase (Influenza A) inhibitor
0,099  0,055  Interleukin 12 antagonist
0,052  0,009  Cholesterol absorption inhibitor
0,058  0,015  Geranyltranstransferase inhibitor
0,073  0,030  Plasminogen activator inhibitor
0,050  0,007  Cholecystokinin agonist
0,073  0,031  Prostaglandin EP2 antagonist
0,064  0,021  Leukotriene C antagonist
0,046  0,003  Vanilloid 2 agonist
0,071  0,029  Glutamate (mGluR1) antagonist
0,172  0,130  5 Hydroxytryptamine 3E antagonist
0,063  0,022  Metalloproteinase-3 inhibitor
0,064  0,023  Diacylglycerol O-acyltransferase inhibitor
0,055  0,014  Dopamine D5 agonist
0,047  0,007  Urotensin II agonist
0,061  0,022  Glutamate (mGluR group I) agonist
0,070  0,031  Collagenase 3 inhibitor
0,052  0,013  Aggrecanase 1 inhibitor
0,069  0,030  Cathepsin E inhibitor
0,070  0,032  Antimycoplasmal
0,127  0,088  Farnesoid X receptor antagonist
0,065  0,026  Opioid agonist
0,058  0,020  Purinergic P2Y antagonist
0,077  0,039  Peroxisome proliferator-activated receptor gamma antagonist
0,159  0,122  Antiparasitic
0,040  0,003  Tryptophan hydroxylase 1 inhibitor
0,061  0,024  Dipeptidyl peptidase inhibitor
0,070  0,033  Narcolepsy treatment
0,063  0,026  Thromboxane A2 antagonist
0,121  0,085  Liver cirrhosis treatment
0,045  0,009  Bradykinin B2 receptor agonist
0,037  0,002  Phosphoribosylglycinamide formyltransferase inhibitor
0,045  0,010  Prostaglandin D2 agonist
0,048  0,013  Trypsin I inhibitor
0,124  0,089  Neurotrophic factor
0,050  0,016  Factor XIIIa inhibitor
0,040  0,005  Lysophosphatidic acid receptor 1 agonist
0,044  0,010  Lysophosphatidic acid 2 receptor antagonist
0,048  0,014  Glutamate (mGluR2) agonist
0,063  0,030  Thromboxane antagonist
0,043  0,010  Methionyl aminopeptidase 1 inhibitor
0,086  0,053  D-Ala-D-Ala ligase inhibitor
0,111  0,079  Transcription factor STAT6 inhibitor
0,039  0,006  Integrin alpha2beta1 antagonist
0,060  0,028  Epithelial sodium channel blocker
0,036  0,004  Ileal bile acid transport inhibitor
0,035  0,004  Isoleucine-tRNA ligase inhibitor
0,051  0,020  Dipeptidyl peptidase IV inhibitor
0,038  0,007  Integrin beta5 antagonist
0,107  0,076  Neutropenia treatment
0,109  0,078  Menstruation disorders treatment
0,062  0,032  Lipocortins synthesis agonist
0,032  0,001  Excitatory amino acid transporter 4 inhibitor
0,110  0,081  Retinopathy treatment
0,038  0,009  LFA antagonist
0,059  0,030  Leukotriene B4 antagonist
0,073  0,045  Secretase beta inhibitor
0,137  0,109  Nitric oxide antagonist
0,145  0,116  Antihelmintic
0,049  0,020  Neurokinin 2 agonist
0,053  0,025  Collagenase inhibitor
0,047  0,020  Sphingosine kinase 1 inhibitor
0,049  0,023  Parathyroid hormone antagonist
0,037  0,011  NMDA 2D receptor antagonist
0,040  0,014  Growth factor receptor-bound protein 2 antagonist
0,030  0,005  GABA transporter inhibitor
0,049  0,024  Leukocyte elastase inhibitor
0,043  0,018  Phosphoglycerate kinase inhibitor
0,039  0,014  HCV polyprotein inhibitor
0,113  0,088  Allergic rhinitis treatment
0,030  0,005  Caspase 8 inhibitor
0,031  0,007  Integrin alpha4beta1 antagonist
0,066  0,042  Neuraminidase (influenza) inhibitor
0,081  0,057  Sleep apnea treatment
0,059  0,035  Postcoital contraceptive
0,057  0,033  Immunoglobulin Fc receptor antagonist
0,035  0,012  Caspase 6 inhibitor
0,041  0,017  Sirtuin 2 inhibitor
0,037  0,013  Hypoxanthine phosphoribosyltransferase inhibitor
0,032  0,008  Prostaglandin F2 alpha agonist
0,027  0,004  Telomerase stimulant
0,033  0,010  Antibiotic Naphthyridine-like
0,049  0,026  Carbonic anhydrase IV inhibitor
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,065  0,042  Antiemphysemic
0,039  0,016  HMG CoA reductase inhibitor
0,040  0,017  Amino-acid-polyamine-organocation (APC) transporter antagonist
0,050  0,027  Farnesyltransferase inhibitor
0,054  0,031  Prolyl endopeptidase inhibitor
0,219  0,198  Antineoplastic (small cell lung cancer)
0,133  0,111  CF transmembrane conductance regulator agonist
0,025  0,004  Thromboxane A2 agonist
0,051  0,030  Antibiotic Glycopeptide-like
0,030  0,010  Aminopeptidase P inhibitor
0,039  0,018  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,032  0,012  Baculoviral IAP repeat-containing protein 4 inhibitor
0,095  0,074  Carbonic anhydrase XV inhibitor
0,099  0,079  Protein kinase C gamma inhibitor
0,062  0,041  Neuraminidase inhibitor
0,113  0,093  Antibacterial (Helicobacter pylori)
0,074  0,054  Carbonic anhydrase XIII inhibitor
0,036  0,016  ATP citrate lysase inhibitor
0,056  0,037  Sphingosine kinase 2 inhibitor
0,041  0,022  Leukotriene C4 antagonist
0,039  0,019  RNA-directed RNA polymerase inhibitor
0,031  0,012  Prostaglandin H2 antagonist
0,039  0,020  Opioid delta receptor agonist
0,032  0,013  Purinergic P2Y15 antagonist
0,026  0,006  Cholecystokinin A agonist
0,057  0,038  Pregnane X receptor antagonist
0,024  0,005  Methylmalonyl-CoA mutase inhibitor
0,146  0,128  Phobic disorders treatment
0,023  0,005  Thyroid hormone alpha agonist
0,054  0,036  Heparanase inhibitor
0,045  0,027  Guanylate cyclase inhibitor
0,222  0,205  CYP2C19 inhibitor
0,022  0,005  Integrin alphaVbeta6 antagonist
0,022  0,005  Lysophosphatidic acid receptor 3 agonist
0,044  0,027  Growth hormone release inhibitor
0,021  0,004  Carboxypeptidase B2 inhibitor
0,067  0,050  Gaucher disease treatment
0,038  0,021  Retinoid X alpha receptor agonist
0,067  0,050  Carbonic anhydrase VA inhibitor
0,094  0,078  HDL-cholesterol increasing
0,129  0,113  Male reproductive disfunction treatment
0,043  0,027  Angiotensin AT1 receptor antagonist
0,032  0,016  Uridine phosphorylase inhibitor
0,089  0,073  Xanthine oxidase inhibitor
0,067  0,051  Elastase 1 inhibitor
0,036  0,021  Angiotensin II receptor antagonist
0,025  0,011  ICAM 1 antagonist
0,037  0,023  Sphingosine 1-phosphate receptor 3 agonist
0,021  0,006  Purinergic P2Y1 agonist
0,035  0,021  Calcium-independent phospholipase A2 inhibitor
0,031  0,018  Glutamate (mGluR2) antagonist
0,018  0,005  Calcium-dependent phospholipase A2 inhibitor
0,039  0,026  Factor VIIa inhibitor
0,021  0,008  Dipeptidyl peptidase IX inhibitor
0,053  0,040  DNA helicase inhibitor
0,026  0,013  Purinergic P2T antagonist
0,017  0,005  Carbonic anhydrase XI inhibitor
0,078  0,066  Antiprotozoal activity enhancer
0,020  0,008  Granulocyte colony stimulating factor receptor agonist
0,020  0,009  Angiotensin-converting enzyme 2 inhibitor
0,020  0,009  Nicotinic acid receptor 1 antagonist
0,018  0,007  CXC chemokine 4 receptor agonist
0,020  0,008  Prostacyclin agonist
0,022  0,011  Retinoid X beta receptor antagonist
0,078  0,067  Caspase 7 inhibitor
0,061  0,050  Leukotriene antagonist
0,017  0,007  GABA transporter 1 inhibitor
0,045  0,034  Plasmin inhibitor
0,015  0,005  Integrin alphaVbeta5 antagonist
0,040  0,030  Thymidine kinase inhibitor
0,020  0,010  Antibiotic Anthracycline-like
0,024  0,013  Geranylgeranyltransferase inhibitor
0,035  0,025  Retinoid X receptor agonist
0,018  0,008  Dipeptidyl peptidase VIII inhibitor
0,016  0,006  Integrin beta6 antagonist
0,034  0,024  Free fatty acid receptor 1 antagonist
0,030  0,020  Factor VII inhibitor
0,026  0,016  Complement factor 1s inhibitor
0,047  0,038  Cytokine production stimulant
0,018  0,009  Glucagon agonist
0,085  0,076  Protein kinase C zeta inhibitor
0,029  0,021  Glucagon receptor antagonist
0,051  0,043  Carbonic anhydrase VB inhibitor
0,013  0,005  Thromboxane agonist
0,058  0,051  Corticotropin releasing factor 2 receptor antagonist
0,064  0,056  Endocannabinoid uptake inhibitor
0,055  0,047  Bombesin 1 receptor agonist
0,036  0,029  Retinoid X receptor antagonist
0,019  0,012  Apical sodium codependent bile acid transporter inhibitor
0,016  0,009  Carbonic anhydrase IV stimulant
0,033  0,027  Somatostatin 5 agonist
0,021  0,015  Lysophosphatidic acid 1 receptor antagonist
0,064  0,058  Exportin-1 inhibitor
0,060  0,054  Carbonic anhydrase V inhibitor
0,018  0,012  Free fatty acid receptor 1 agonist
0,023  0,018  NMDA receptor glycine site antagonist
0,026  0,021  Leukotriene B4 receptor 1 antagonist
0,027  0,022  Thrombin receptor antagonist
0,020  0,015  Neurokinin 1 agonist
0,034  0,029  5-Alpha-reductase inhibitor
0,056  0,051  Ryanodine receptor antagonist
0,045  0,040  Carbonic anhydrase XIV inhibitor
0,016  0,012  Vitamin D receptor agonist
0,047  0,043  Prostaglandin antagonist
0,029  0,025  Prostaglandin agonist
0,034  0,030  Somatostatin 1 antagonist
0,008  0,004  Integrin alpha5beta6 antagonist
0,015  0,012  Thyroid hormone alpha antagonist
0,109  0,106  Skin whitener
0,052  0,049  Kallikrein 1 inhibitor
0,082  0,079  Polo-like kinase-1 inhibitor
0,033  0,031  Adenosine uptake inhibitor
0,045  0,043  Dopamine beta hydroxylase inhibitor
0,011  0,010  Integrin beta2 antagonist
0,008  0,007  Thyroid hormone beta agonist
0,066  0,065  CDC25A inhibitor
0,020  0,019  Growth hormone releasing factor antagonist
0,039  0,038  Nerve growth factor antagonist
0,151  0,150  Cyclic AMP phosphodiesterase inhibitor
0,012  0,011  Integrin alphaLbeta2 antagonist
0,015  0,015  Vesicular glutamate transport inhibitor
0,010  0,009  Neurokinin 3 agonist
0,019  0,019  Prostaglandin EP2 agonist

